logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sarah J. Kennedy

marine biological laboratory - woods hole
H指数:10
被引数:1,132

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients

一项为期28周的III期、多中心、随机、双盲、安慰剂对照试验（OA-10），旨在评估中度至重度症状性骨关节炎患者靶膝关节单次注射lorecivivint的疗效和安全性。

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
IF3.3
2024-03-030
PRE
Yazici, Y.; Tambiah, J. R. S.; Swearingen, C. J.; Lopez, V. A.; Kennedy, S.; Fineman, M. S.; Simsek, I.; Solomon, E.; McAlindon, T. E.
Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment

Lorecivivivint通过抑制CLK2和DYRK1A来调节Wnt途径，作为一种新的，潜在的疾病修饰方法，用于治疗膝骨关节炎

OSTEOARTHRITIS AND CARTILAGE
IF9
2019-09-01131
OAAI
Deshmukh, V.; O'Green, A. L.; Bossard, C.; Seo, T.; Lamangan, L.; Ibanez, M.; Ghias, A.; Lai, C.; Do, L.; Cho, S.; Cahiwat, J.; Chiu, K.; Pedraza, M.; Anderson, S.; Harris, R.; Dellamary, L.; Kc, S.; Barroga, C.; Melchior, B.; Tamz, B.; Kennedy, S.; Tambiah, J.; Hood, J.; Yazici, Y.

研究方向

暂未获取到该数据
J
J. Tambiah
H 指数:16论文数:76被引数:1,293
C
Christopher J. Swearingen
H 指数:33论文数:172被引数:4,380
L
Lindsey N. Shaw
H 指数:40论文数:183被引数:5,754
Y
Yusuf Yazıcı
H 指数:52论文数:416被引数:1.0万
B
Bill J. Baker
H 指数:51论文数:292被引数:7,159
R
Rebecca N. Cliffe
H 指数:6论文数:14被引数:143
J
Judy Avey‐Arroyo
H 指数:9论文数:29被引数:209
T
Timothy E. McAlindon
H 指数:66论文数:354被引数:2.7万
R
Rory P. Wilson
H 指数:73论文数:398被引数:1.8万
Ł
Łukasz Wojtas
H 指数:87论文数:884被引数:2.6万